← Eichor
Study identifier: NCT07562542 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis

Condition: Systemic Mastocytosis · KIT-D816V Mutation  ·  Sponsor: The First Affiliated Hospital of Soochow University

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This observational study aims to evaluate the diagnostic value and clinical utility of detecting the KIT-D816V mutation in the peripheral blood of adult patients with systemic mastocytosis (SM), using droplet digital PCR (ddPCR). Currently, the diagnosis of SM relies heavily on invasive bone marrow biopsies. This study will determine whether highly sensitive ddPCR testing of peripheral blood could provide a reliable, minimally invasive alternative for detecting the KIT-D816V mutation, which is a key driver of the disease and a major diagnostic criterion. The results could optimize the diagnostic process and continuous monitoring of adult SM patients.

This description comes directly from the study's public registry record.

Talk to the study team

Suning Chen, Professor  ·  +86-13814881746  ·  chensuning@sina.com

Suning Chen Chen, Professor  ·  +86-13814881746  ·  chensuning@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of Soochow University, Jiangsu Institute of HematologySuzhou, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07562542